IGF2BP3 as a Prognostic Biomarker in Well-Differentiated/Dedifferentiated Liposarcoma

By sjmartinez • September 28, 2023

Klingbeil KD, Tang JP, Graham DS, Lofftus SY, Jaiswal AK, Lin TL, Frias C, Chen LY, Nakasaki M, Dry SM, Crompton JG, Eilber FC, Rao DS, Kalbasi A, Kadera BE. IGF2BP3 as a Prognostic Biomarker in Well-Differentiated/Dedifferentiated Liposarcoma. Cancers (Basel). 2023 Sep 9;15(18):4489. doi: 10.3390/cancers15184489. PMID: 37760460.

Tags: dedifferentiated liposarcoma, DOM STAT, gene microarray, General Internal Medicine, Hematology/Oncology, IGF2BP3, IMP3, liposarcoma, prognostic biomarker, Publications, soft-tissue sarcoma, TCGA, tissue microarray, well-differentiated liposarcoma

Neighborhood-level characteristics as effect modifiers on the efficacy of the MyPEEPS mobile intervention in same-sex attracted adolescent men

Cordoba E, Garofalo R, Kuhns LM, Pearson C, Scott Batey D, Janulis P, Jia H, Bruce J, Hidalgo MA, Hirshfield S, Radix A, Belkind U,[...]

COVID-19 pandemic and trends in clinical outcomes and medication use for patients with established atrial fibrillation: A nationwide analysis of claims data

Hernandez I, Yang L, Tang S, Cameron T, Guo J, Gabriel N, Essien UR, Magnani JW, Gellad WF. COVID-19 pandemic and trends in clinical outcomes[...]

Screening for Breast Cancer: US Preventive Services Task Force Recommendation Statement

US Preventive Services Task Force; Nicholson WK, Silverstein M, Wong JB, Barry MJ, Chelmow D, Coker TR, Davis EM, Jaén CR, Krousel-Wood M, Lee S,[...]